Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-25

Clinical Trial Update: Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating HDM1002 tablets for type 2 diabetes mellitus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HDM1002 (HDM1002)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: RECRUITING